Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone vs sufentanil for postoperative pain control in pediatric hip surgery
ChiCTR-IPR-15007641Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Lanzhou University Second Hospital
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Hydromorphone PCIA with Sufentanil PCIA (2 arms). Primary endpoints: Resting FLACC score, Moving FLACC score and 2 more. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
hydromorphonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-15007641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007641.